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Introduction.Cesareansectionisanindependentriskfactorforperipartumhysterectomy.Asamethodofdelivery,cesareansection
may interfere with a number of molecular changes that occur at the maternal-fetal interface during the course of labor. Methods.
The level of CD3, CD56, CD25, and CD69 antigen immunoreactivity was assessed by immunohistochemistry in 26 decidual tissue
samples. The tissue samples were obtained from 18 women who underwent cesarean sections at term and from 8 women who
underwent cesarean hysterectomies. Results. An increase in the activity and inﬁltration of immune cells in the decidua sampled
during the spontaneous beginning of labor was observed. The further progression of labor was accompanied by a decrease in the
number and activity of immune cells. The number of CD56+ and CD3+ cells in the decidua was statistically signiﬁcantly lower in
patients who had undergone cesarean hysterectomies than in those who had had cesarean sections at term. Conclusion. Abnormal
immune response during labor may increase the risk for peripartum hysterectomy.
Copyright © 2007 L. Wicherek and K. Galazka. This isan open access article distributed underthe Creative CommonsAttribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Peripartum hysterectomy, a life-saving procedure, is per-
f o r m e dm o r eo f t e no nw o m e nw h oh a v eu n d e r g o n ec e s a r e a n
sections (cesarean hysterectomy) than on those who expe-
rience normal labor (postpartum-hysterectomy) [1]. Most
studiesreporttherateofoccurrenceforperipartumhysterec-
tomies as between 0.2 and 1.5 per 1000 deliveries [2–4]. In
somestudies,however,theincidenceisreportedtobeashigh
as 2.25 or 2.7 per 1000 deliveries [1, 5]. The chief indica-
tions for hysterectomy are abnormal placental detachment
and atonic postpartum hemorrhage [1]. In recent years, a
signiﬁcant increase in peripartum hysterectomies has been
reported, and this increase would seem to correlate with an
increase in the number of cesarean sections performed [2].
Not only does cesarean delivery increase the risk for emer-
gency peripartum hysterectomy [4–7], but in cases of repeat
cesarean sections there is an associated increase in the risk of
a number of other complications, such as abnormal placen-
tation, placenta previa, or uterine sparring [2, 8, 9].
Electivecesareansection(cesareansectionwithoutlabor)
is performed before the physiological alteration of immune
tolerance associated with pregnancy and the beginning of
spontaneous labor has occurred. The level of immune tol-
erance during newborn expulsion at term in cases of elec-
tive cesarean section appears to diﬀer from the level found
in cases of spontaneous vaginal delivery at term. Molecu-
lar changes at the maternal-fetal interface are the pivotal
mechanism in the alteration of the immune tolerance phe-
nomenon. These changes lead to an increase in the activ-
ity of the maternal and fetal immunological systems [10–
14]. During spontaneous vaginal delivery, a decrease in pla-
cental factors suppressing maternal immune response, in-
cluding Fas-L, RCAS1 and HLA-G, has been observed along
with a drop in the number of CD4CD25 positive sup-
pressive lymphocytes within the decidua [15–19]. On ac-
countoftheirimmunomodulatingactivity,decidualcells,to-
getherwithplacentalandmaternalimmunecells,alsopartic-
ipate in the development of immune tolerance phenomenon
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In the present study we have aimed to assess the num-
ber and activity of immune cells in the decidua using sam-
ples collected from patients who have had term cesarean sec-
tions and from patients who have had postcesarean hysterec-
tomies.
2. MATERIALS AND METHODS
2.1. Patients
The decidual tissue samples evaluated in our study were ob-
tained from 26 pregnant women who underwent cesarean
sections. 18 of the tissue samples were obtained during ce-
sarean sections at term, and 8 from cesarean hysterectomy
specimens. Those patients undergoing cesarean section at
term (18 cases) were selected from 650 women undergoing
cesarean sections in the Department of Gynecology, Obstet-
rics and Oncology, Jagiellonian University, Krakow, Poland,
in 2005. Patients with multiple pregnancies or existing com-
plications of pregnancy, such as preterm deliveries, hyper-
tension, diabetes mellitus, and cases of fetal demise, were
excluded from the present study. For the purpose of this
study, the histories of patients who had undergone emer-
gency cesarean hysterectomies between 1999 and 2004 were
analyzed and 8 were selected. Women on whom peripar-
tum hysterectomies had been performed due to uterine can-
cer during pregnancy were also excluded from our analy-
sis. The tissue samples derived from the women undergoing
cesarean section at term and obtained during surgical pro-
cedures were thereafter immediately ﬁxed in 10% buﬀered
formaldehydesolutionandsenttothePathomorphologyDe-
partment, Jagiellonian University (Karkow, Poland). The de-
cidual tissue samples from the patients having undergone
emergency hysterectomies were obtained from the archive
ﬁles of the Department of Pathomorphology of the Jagiel-
lonian University. The experienced pathomorphologist (K.
Galazka) evaluated the routinely stained (hematoxylin and
eosin) slides prepared from paraﬃn-embedded tissue mate-
rial and selected the material adequate for further analysis.
Chosen paraﬃn blocks were cut and used for immunohisto-
chemistry.
The patient’s consent was obtained in each case.
2.2. Immunohistochemistry
Immunohistochemical analysis was performed in the Path-
omorphology Department of the Jagiellonian University.
Four-micrometer slides from each case, encompassing the
decidua, prepared routinely for immunohistochemistry,
were stained to visualize the CD3, CD69, CD25, CD56-
positive cells (lymphocytes).
In all instances, immunohistochemistry was performed
by applying the Envision method using Dako Autostainer.
Thefollowingantibodieswereapplied:CD56(NCAM;NCL-
CD56-504, Novocastra) in dilution 1 : 100, CD69 (NCL-
CD69, Novocastra) in dilution 1 : 25, CD25 (Interleukin-2
Receptor, NCL-CD25-305, Novocastra) in dilution 1 : 25,
CD3 (NCL-CD3p, rabbit polyclonal antibody, Novocastra)
in dilution 1 : 100, according to the manufacturer’s instruc-
tions. Visualization of reaction products was performed us-
ing AEC (3-amino-9-ethyl-carbazole) as a chromogen (AEC
SubstrateChromogenready-to-use,DAKO,Denmark)for10
minutes at room temperature. Sections were counterstained
with hematoxylin and mounted in glycergel. The numbers
of diﬀerent lymphocytes in the decidua were evaluated. The
number of immune cells in an entire specimen and an aver-
age cell number per 1hpf (high power ﬁeld, objective magni-
ﬁcation ×40) were calculated. The following scale was used
to evaluate the number of cells semiquantitatively: 0—lack
of positive cells; +1—1–5 positive cells per 1hpf; +2—6–10
positive cells/1hpf, +3—11–20 positive cells/1hpf; +4—more
than 20 positive cells per 1hpf.
2.3. Statisticalanalysis
The distribution of variables in the groups of women studied
checked with the use of the Shapiro-Wilk test showed that all
of the women were diﬀerent from normal. Therefore, non-
parametric testing was employed. The diﬀerences between
the groups were determined by the Kruskal-Wallis analysis of
variance (ANOVA) test. The Mann-Whitney U test was then
used as applicable.
3. RESULTS
3.1. Clinicalcomparisonofanalyzedgroups
ofpatients:cesareansectionattermand
peripartumhysterectomy
Since cesarean section is performed at diﬀerent times dur-
ing pregnancy, it seems important to compare the parame-
ters characterizing the course of pregnancy and labor in the
respective groups of patients studied (see Table 1).
When compared, the basic diﬀerence between the groups
was related to the parity of the pregnant women studied.
Multiparity is an independent risk factor for emergency hys-
terectomy [7] that could also be related to the status of im-
mune tolerance during pregnancy. The central question of
this study is whether the number and activity of immune
cells at the maternal fetal interface correlates with the level
of immune tolerance during pregnancy.
3.2. Immunohistochemicalanalysisoftheimmune
cellspresenceandtheiractivity
CD3 positive cells were identiﬁed in all the decidual tissue
samples derived from patients who had undergone cesarean
sections at term and in 25% of the decidual tissue samples
derived from patients having had cesarean peripartum hys-
terectomies. CD56 positive cells were observed in 60% of the
decidual tissue samples derived from those patients having
had cesarean sections at term and in 13% of decidua tis-
sue samples derived from patients having had cesarean peri-
partumhysterectomies.CD69antigenimmunoreactivitywas
observed in 40% of the tissue samples derived from those
having undergone cesarean sections at term and in 38% of
the tissue samples derived from those having had cesarean
peripartum hysterectomies.CD25 antigen immunoreactivityL. Wicherek and K. Galazka 3
Table 1: Clinical characteristic of patients.
Variables Cesarean section at Emergency cesarean P value
term (n = 18) hysterectomy (n = 8)
Maternal age (average ± SD∗) 28.6 (±5.7) 38.6 (±7.5) .0003
Parity (median ± SEM) 1 (±0.20) 4 (±0.64) .00008
Gestational age (average ± SD) 38.5 (±1.29) 38.12 (±1.35) .3
Newborn mass (average ± SD) 3031 (±530) 2937 (±425) .57
Newborn length (average ± SD) 50.11 (±2.69) 52.50 (±3.5) .33
Apgar score (median ± SEM) 9 (±0.29) 9 (±0.29) .7
∗SD: standard deviation.
Table 2: Immunoreactivity of CD3, CD56, CD69, and CD25 antigens within decidua from patients who underwent cesarean section at term
and those who underwent an emergency cesarean hysterectomy.
Groups Antigen
Immunoreactivity
∗percent (number of cases)
0 + 1+ 2+ 3+ 4
Cesarean hysterectomy (n = 8)
CD3 75 (6) 0 (0) 0 (0) 0 (0) 25 (2)
CD69 62 (5) 13 (1) 25 (2) 0 (0) 0 (0)
CD56 87 (7) 13 (1) 0 (0) 0 (0) 0 (0)
CD25 100 (8) 0 (0) 0 (0) 0 (0) 0 (0)
Cesarean section at term (n = 18)
CD3 0 (0) 50 (9) 6 (1) 28 (5) 16 (3)
CD69 55 (10) 33 (6) 6 (1) 6 (1) 0 (0)
CD56 40 (7) 22 (4) 22 (4) 10 (2) 6 (1)
CD25 94 (17) 6 (1) 0 (0) 0 (0) 0 (0)
∗Percentage of cases (n-number of tissue samples).
wasweakinthesamplesderivedfromthegroupwhohadun-
dergone cesarean sections at term; it was not detected in the
samples from the group who had had cesarean peripartum
hysterectomies (see Table 2).
The changes in the number and activity of immune cells
were identiﬁed in the decidua and correlated with the pro-
gression of labor. The study group of patients who under-
went cesareans at term was divided into three subgroups ac-
cording to the degree of uterine cervical ripening and to the
presence of uterine contractions during the surgical proce-
dure. Group A consisted of patients not experiencing uter-
ine contractions and with a closed uterine cervical ostium
(i.e., caesarean without labor); group B consisted of patients
with irregular uterine contractions or the beginning of regu-
lar uterine contractions and cervical dilation between 1 and
3cm (i.e., caesarean section with symptoms indicating the
spontaneous beginning of labor); group C consisted of pa-
tients with regular uterine contractions and cervical dilation
of more than 3cm (i.e., “caesarean with advanced labor”).
The comparison of the number and activity of immune cells
between subgroups is presented in Table 3.
We found a statistically signiﬁcantly higher number of
CD3 positive cells and a higher CD69 antigen immunore-
activity level in the decidua from those on whom cesarean
sections were performed after the spontaneous beginning of
labor (B) in comparison to what was found in the decidua
fromthoseonwhomcesareansectionswereperformedwith-
out labor (A), and from those on whom cesarean sections
wereperformedduring advanced labor(C)(P,r esp .,(C D3 +:
P = .01 and P = .04; CD69: P = .03 in both cases). Although
the number of CD56 positive cells increased with the pro-
gression of labor, the diﬀerences noted were not statistically
signiﬁcant.
3.3. Comparisonofmolecularalterationswithin
deciduaincesareansectionattermandin
cesareanhysterectomy
Our analysis of the indications for cesarean sections (the
number of elective cesarean sections), when taking into con-
sideration such factors as the progression of labor during
surgery and the gestational age both in the group of patients
with cesarean peripartum hysterectomies and in the group
with the cesarean sections at term, did not reveal any sig-
niﬁcant diﬀerences. In the group of patients having had ce-
sareanperipartumhysterectomies,signiﬁcantlyhigherparity
was observed. Also, the average age of these women was sig-
niﬁcantly higher (resp., P = .01 and P = .02).
Our study group consisted of patients with cesarean sec-
tions followed by peripartum hysterectomies who either pre-
sented no symptoms of the spontaneous beginning of the la-
bororwereinitsveryinitialstage.Signiﬁcantly,nowomenin
advanced labor found themselves in this group. The women
selected for the control group were at the same stage of la-
bor as those in the study group (caesarean without labor or
caesareansectionwithsymptomsindicatingthespontaneous
beginning of labor). The number and activity of immune
cells in the decidua of the group of cesarean peripartum4 Clinical and Developmental Immunology
Table 3: The immunoreactivity of CD3, CD56, CD69, CD25 antigens within decidua during the cesarean section.
Cesarean section Cesarean section Cesarean section with symptoms Cesarean section with P value
without labor of spontaneous beginning of labor advanced labor
CD3 (median ± SEM) 1 (±0.25) 3 (±0.32) 1 (±0.49) .0257
CD69 (median ± SEM) 0 (±0.25) 1 (±0.35) 0 (±0.16) .05
CD56 (median ± SEM) 0.5 (±0.28) 1 (±0.56) 2 (±0.42) .47
CD25 (median ± SEM) 0 (±0) 0 (±0.12) 0 (±0) .5
Table 4: Comparison between the number of CD3 positive and CD56 positive cells and the level of immunoreactivity of CD69, and CD25
antigens in case of emergency cesarean hysterectomies and cesarean section at term: control group.
Variables Cesarean section at Emergency cesarean P value
term—control group hysterectomies
CD3 (median ± SEM) 3 (±0.33) 0 (±0.65) .03
CD69 (median ± SEM) 1 (±0.27) 0 (±0.32) .55
CD56 (median ± SEM) 1 (±0.4) 0 (±0.12) .03
CD25 (median ± SEM) 0 (±0.08) 0 (±0) .4
hysterectomies and of the control group were compared. The
results obtained are presented in Table 4.
4. DISCUSSION
An increase in the activity and inﬁltration of immune cells in
thedeciduasampledduringthespontaneousbeginningofla-
bor was observed. Moreover, the further progression of labor
was accompanied by a decrease in the number and activity of
immune cells. The number of CD56 positive and CD3 posi-
tive cells in the decidua was statistically signiﬁcantly lower in
the samples from those having had cesarean hysterectomies
than in the samples of those having had cesarean sections at
term.
Risk factors for emergency peripartum hysterectomy in-
clude cesarean delivery, prior cesarean, placenta praevia, pla-
centa acreta, and grand multiparity [3, 7, 27]. What, then, is
the possible common denominator present in all these dif-
ferent clinical conditions? What common anomaly causing
alterations in immune tolerance during the progression of
labor and increasing the risk for emergency hysterectomy
can we ﬁnd? Spontaneous labor at term involves gradual
changes in maternal immune tolerance. For example, the in-
ﬁltration of leukocytes into the upper and lower uterine seg-
ments seems to play an important role in the course of nor-
mal parturition [13, 28]. A peripartum increase in immune
response has already been described [10, 12, 29, 30]. Elec-
tive cesarean section is a surgical procedure performed prior
to the spontaneous beginning of labor and, therefore, prior
to the molecular changes that are responsible for the initia-
tion and beginning of the course of labor. Cesarean section
is one of the primary risk factors for peripartum hysterec-
tomy [2, 6, 27, 31]. The most common indication for ce-
sareansectionfollowedbyperipartumhysterectomyis malp-
resentation [27], and this is in itself an indication for an elec-
tive cesarean section. In our study, all of the emergency ce-
sarean hysterectomies were performed on patients who had
had elective cesareans. The deﬁcit of inﬁltrating immune cy-
totoxic cells that is associated with the surgical procedure
when performed before the beginning of spontaneous la-
bor may aﬀect the subsequent steps of the immune response.
Therefore, elective cesarean performed without the molecu-
lar alterations responsible for the progression of labor seems
to increase the risk for peripartum hysterectomy.
Abnormal placentation has recently been demonstrated
to be a common indication for cesarean section and has been
found possibly to lead to peripartum hysterectomy. A pre-
vious cesarean increases the risk of abnormal placentation
[7, 31]. The veriﬁcation of placenta percreta in histopatho-
logical analysis means the absence of decidua basalis [9, 32–
34], which may itself be associated with a low number of im-
munecellswithinthedecidua.Inourstudy,placentapercreta
was identiﬁed in 3 patients (37% of cases).
Sindram-Trujillo et al. has observed that the course of
spontaneous vaginal delivery is accompanied by an increase
in the number of immune cells as well as alterations in
their distribution (NK CD56+CD16+ cells and T cell sub-
population) [11, 18]. Bulmer and Lash, however, have ob-
served a decrease in dNK cells in the decidua during the sec-
ond and third trimesters of pregnancy [35]. Spornitz et al.
has suggested that the decrease in the number of these cells
may correlate with their function during the ﬁrst trimester
of pregnancy [36] while the increase in NK cells observed
by Sindram-Trujillo et al. may be associated with the re-
cruitment of new cells to the decidua. Rukavina and Podack
has shown a continuing recruitment of immune cells to the
decidua throughout gestation with concomitant phenotype
changes in peripheral NK cells [37]. Recently, the recruit-
ment of these cells to the decidua was found to result from
the activity of the decidual cells rather than from the phys-
ical presence of the embryo [38]. The beginning of the la-
bor correlates strongly with alterations in the pattern of cy-
tokine concentration in the decidua, including IL-8 and IL-
6[ 39]. Campbell et al. have indicated that the CD56+ cell
population derived from multiple lineages can be discrimi-
nated by the expression of traﬃcking molecules. Moreover,L. Wicherek and K. Galazka 5
CD56+CD16+ cells are extremely sensitive to IL-8 chemo-
tacticactivity[24].Inourstudy,theaccumulationofCD56+,
CD3+ lymphocytes in the decidua began after the initiation
of labor. In patients on whom peripartum hysterectomies
were performed, no such increase was observed, which may
suggest a correlation between the risk for emergency hys-
terectomy and the presence of abnormal immune response
during labor.
Although the presence of uterine leiomyomas was found
to increase the risk of peripartum hemorrhages [40], Sheiner
et al. did not observe any correlation between cesarean hys-
terectomyandtheseneoplasms.Inourstudy,uterineleiomy-
omas were observed in 3 cases of peripartum hysterectomy
[27].
Women with grand multiparity have been identiﬁed as
more predisposed to postpartum hemorrhage [41, 42], and
grand multiparity is furthermore an independent risk factor
for emergency peripartum hysterectomy [4, 7, 9, 27, 33, 43].
In the present study, no nulliparous women were observed
in the group on whom emergency hysterectomies were per-
formed. Maymon et al. has shown that grand multiparity
is an independent risk factor for peripartum complications
such as malpresentation, dysfunctional labor, and massive
hemorrhage[43].Moreover,witheachsucceedingpregnancy
the risk increases, and in the 14th gestation the risk is 3 times
higher than in the 7th [43]. Multiparity is related to the re-
peated development of immune tolerance during pregnancy.
Thus, although our samples are insuﬃcient to prove such
claims, one may conjecture that with each consecutive la-
bor the risk that the woman may not develop the complex
immune response involved in the alteration of immune tol-
erance level during spontaneous labor increases. It has been
shown that great grand multiparity is more frequently asso-
ciated with the disturbance of uterine cervical ripening and
postterm deliveries [42]. Both complications have immuno-
logical backgrounds. For instance, Gabrilovac et al. has ob-
served that multigravidas exhibit a signiﬁcant decline in NK
cell activity [44]. This may be a predictor of immune re-
sponse disturbance in any subsequent pregnancies.
The present study has had certain limitations. First, the
small number of patients involved does not allow us to posit
that abnormal immune cell activity is a risk factor for emer-
gency hysterectomy. We can only suggest, on the basis of
trends,thataprobableassociationexistsbetweenanimmune
response disturbance during labor and the need for emer-
gency hysterectomy. This probable correlation will have to be
explored in more detail in further investigations.
5. CONCLUSION
Abnormal immune response during labor may increase the
risk for peripartum hysterectomy.
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